Literature DB >> 11445796

Predictors of cost of liver transplantation in children: a single center study.

J C Bucuvalas1, F C Ryckman, H Atherton, M P Alonso, W F Balistreri, U Kotagal.   

Abstract

OBJECTIVE: Efforts to decrease the cost of orthotopic liver transplantation (OLT) must address the impact of specific interventions on clinical outcome. We hypothesized that an intervention designed to decrease the length of hospitalization would reduce costs without jeopardizing clinical outcome. We further sought to identify predictors of length of stay and cost for hospitalization after liver transplantation.
METHODS: The study group included 47 children who underwent OLT from September 1996 to April 1999, and the control group included 36 children who underwent OLT from March 1994 to August 1996. The intervention was a transition to home program in which patients were discharged to a family living center when they met established clinical criteria and their families met predefined educational goals. We analyzed patients who survived 3 months after OLT.
RESULTS: For the intervention group, the mean length of stay, total costs, and surgical costs were 29%, 36%, and 34% lower, respectively. Organ type, height z score, race, hepatic artery thrombosis, early allograft rejection, and participation in the transition to home program predicted length of stay and total costs.
CONCLUSION: An early discharge program based on defined criteria can be used to decrease length of stay and cost after OLT without jeopardizing clinical outcome.

Entities:  

Mesh:

Year:  2001        PMID: 11445796     DOI: 10.1067/mpd.2001.115068

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  7 in total

1.  Cytokine-Producing B Cells Promote Immune-Mediated Bile Duct Injury in Murine Biliary Atresia.

Authors:  Joseph Bednarek; Brianna Traxinger; Dania Brigham; Jonathan Roach; David Orlicky; Dong Wang; Roberta Pelanda; Cara L Mack
Journal:  Hepatology       Date:  2018-07-10       Impact factor: 17.425

2.  Regulatory T cells inhibit Th1 cell-mediated bile duct injury in murine biliary atresia.

Authors:  Rebecca M Tucker; Amy G Feldman; Erika K Fenner; Cara L Mack
Journal:  J Hepatol       Date:  2013-05-14       Impact factor: 25.083

Review 3.  The pathogenesis of biliary atresia: evidence for a virus-induced autoimmune disease.

Authors:  Cara L Mack
Journal:  Semin Liver Dis       Date:  2007-08       Impact factor: 6.115

Review 4.  The Sea Lamprey as an Etiological Model for Biliary Atresia.

Authors:  Yu-Wen Chung-Davidson; Chu-Yin Yeh; Weiming Li
Journal:  Biomed Res Int       Date:  2015-05-26       Impact factor: 3.411

5.  Predictors of micro-costing components in liver transplantation.

Authors:  Luciana Bertocco de Paiva Haddad; Liliana Ducatti; Luana Regina Baratelli Carelli Mendes; Wellington Andraus; Luiz Augusto Carneiro D'Albuquerque
Journal:  Clinics (Sao Paulo)       Date:  2017-06       Impact factor: 2.365

6.  Direct health care cost of treatment and medication of biliary atresia patients using the National Database of Health Insurance Claims and Specific Health Checkups.

Authors:  Eri Hoshino; Keiko Konomura; Masayuki Obatake; Kensuke Moriwaki; Michi Sakai; Kevin Y Urayama; Kojiro Shimozuma
Journal:  Pediatr Surg Int       Date:  2022-02-15       Impact factor: 1.827

7.  Programmed cell death protein-1 (PD-1) protects liver damage by suppressing IFN-γ expression in T cells in infants and neonatal mice.

Authors:  Xuangjie Guo; Yiping Xu; Wei Luo; Rongli Fang; Li Cai; Ping Wang; Yuxia Zhang; Zhe Wen; Yanhui Xu
Journal:  BMC Pediatr       Date:  2021-07-16       Impact factor: 2.125

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.